Legal Representation
Attorney
Tony Bortolin
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 12, 2016 | MAB1 | O | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | Loading... |
| Aug 12, 2016 | ABN1 | O | ABANDONMENT - EXPRESS MAILED | Loading... |
| Aug 11, 2016 | EXAR | I | TEAS EXPRESS ABANDONMENT RECEIVED | Loading... |
| Jul 1, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 1, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 1, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 29, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 24, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 24, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
vitamin supplements, mineral supplements, dietary supplements for general health and well-being, dietary and herbal supplements for the treatment of cancer; nutritional supplements; dietary supplements; Medical clinic services; infusion clinic services; Medical treatment services, namely, medical treatment of cancer; medical services in the form of cancer treatment; medical services in the form of curable advanced disease treatment; medical services in the form of incurable advanced disease treatment; medical services through ultrasound sonography treatment; medical service for all advanced and non-advanced diseases through injections; medical services for all advanced and non-advanced diseases through suppositories; medical services for all advanced and non-advanced diseases through nebulization; research in the field of advanced cancer treatment; research in the field of recurring cancer treatment; research in the field of curable and incurable disease treatment; providing on-line information in the field of medical treatment services; providing on-line information in the field of oncology; providing on-line information in the field of advanced diseases; adjunct treatment of cancer through nutritional supplements; nutritional and dietary guidance for all patients and public at large; ketogenic diet design and guidance for cancer patients
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
044